Albireo Pharma Inc
(ALBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 09-2015 | 09-2014 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,350 | -13,755 | -18,737 | -14,131 | -19,335 |
| Depreciation Amortization | 1,079 | 81 | 197 | 603 | 641 |
| Accounts receivable | 1,104 | N/A | N/A | 26 | 71 |
| Accounts payable and accrued liabilities | -1,164 | -271 | 249 | -74 | -39 |
| Other Working Capital | 3,267 | 699 | 478 | -872 | -182 |
| Other Operating Activity | 3,280 | 702 | -390 | -4,275 | 289 |
| Operating Cash Flow | $-8,784 | $-12,544 | $-18,203 | $-18,723 | $-18,555 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | 404 | 7 | -49 | -118 |
| Net Acquisitions | 25,483 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $25,480 | $404 | $7 | $-49 | $-118 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,157 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 79 | N/A | 32,821 | 538 | 19,314 |
| Common Stock Repurchased | N/A | N/A | 41 | 15 | 30 |
| Other Financing Activity | 9,690 | -21 | 1,591 | 3,026 | 60 |
| Financing Cash Flow | $7,612 | $-21 | $34,453 | $3,579 | $19,404 |
| Exchange Rate Effect | 503 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 5,120 | 40,845 | 24,588 | 39,781 | 39,050 |
| End Cash Position | 29,931 | 28,684 | 40,845 | 24,588 | 39,781 |
| Net Cash Flow | $24,811 | $-12,161 | $16,257 | $-15,193 | $731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,784 | -12,544 | -18,203 | -18,723 | -18,555 |
| Capital Expenditure | -3 | N/A | N/A | -49 | -118 |
| Free Cash Flow | -8,787 | -12,544 | -18,203 | -18,772 | -18,673 |